Cerebyx Articles
Industry bodies oppose annual revision of Japan
7 August 2006
Tokyo pharma stocks - week to July 29
5 August 2002
Brand name confusion "a risk for patients"
27 May 2002
Pfizer/Monsanto act on drug name confusion
1 September 1999
Showing 1-5 of 5 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
